CRH delivered a strong performance in 2023 supported by good underlying demand in key end-use markets, positive pricing and contributions from acquisitions. Total revenues of $34.9 billion (2022: $32.7 billion) were 7% ahead of 2022 while organic revenues* were 3% ahead. Income from continuing operations was 14% ahead of 2022 at $3.1 billion (2022: $2.7 billion) and Adjusted EBITDA* of $6.2 billion (2022: $5.4 billion) was 15% ahead, reflecting the continued delivery of our integrated solutions strategy, strong commercial management, ongoing cost control and further operational efficiencies. Organic Adjusted EBITDA* was 10% ahead of 2022. CRH's income from continuing operations margin of 8.8% (2022: 8.2%) and Adjusted EBITDA margin* of 17.7% (2022: 16.5%) were ahead of the prior year.
CRH's earnings per share from continuing operations was 22% higher than 2022 at $4.36 (2022: $3.58). Earnings per share pre-impairment* from continuing operations was 30% higher than 2022 at $4.65 (2022: $3.58).